United States · Series A startup

Who invested in Sorriso Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$31Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $31MDec 2021
Investors
1
See who backed them

The rounds

  1. Dec 2021
    Series A$31M

    Source recordedSEC filing: $21M sold, first sale Dec 2021

Founders and team

From the SEC filings it signed: 3 on the team.

  • Brian DorseyExecutive Officeri
  • Ciara KennedyExecutive Officer, Directori
  • Susan DubeExecutive Officeri

On the board, as filediEdward MathersMark ChinMichael Grey

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Sorriso Pharmaceuticals

Who invested in Sorriso Pharmaceuticals?

Sorriso Pharmaceuticals's investors include New Enterprise Associates.

How much has Sorriso Pharmaceuticals raised?

Sorriso Pharmaceuticals has raised $31M across 1 round since 2021.

When did Sorriso Pharmaceuticals last raise?

Sorriso Pharmaceuticals's most recent round was a Series A of $31M in Dec 2021.

What was Sorriso Pharmaceuticals's biggest round?

Its most recent round, $31M in Dec 2021, is also its largest on record.

Who backed Sorriso Pharmaceuticals first?

Sorriso Pharmaceuticals's first round on record, in Dec 2021, was backed by New Enterprise Associates.

What stage is Sorriso Pharmaceuticals at?

Sorriso Pharmaceuticals's latest named round is a Series A, in Dec 2021.

Where is Sorriso Pharmaceuticals based?

Sorriso Pharmaceuticals is based in the United States.

Companies like Sorriso Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.